Simon Mcdade News Today

AN initiative to support smaller businesses who are actively trying to raise capital to help them become investor ready is preparing to welcome applications for the second cohort of SMEs this September.

BioEquity Europe is coming to Dublin this year, giving biotech life sciences start-ups the chance to attract international investment.

START-up firm AilseVax, which is developing the next generation of cancer vaccines, has become the 100th company to spin out of the laboratories at Belfast's Queen’s University.

Queen’s University Belfast has announced its 100th spin-out company - AilseVax - with seed funding of £1.5M from a group of investors.

  Thousands of weaknesses known as “Achilles heels” have been identified in more than 700 different cancer cell types by researchers at Queen’s University Belfast. The discovery of the “cancer vulnerabilities”, using DNA technology and computer analysis of large volumes of genetic data, could lead to new ways to stop cancer cells in their tracks. This could be done by using existing drugs as well as generating potentially new targets for drug development through enhan...